Centre Hospitalier Universitaire de Québec, Hôtel-Dieu de Québec
Québec, Quebec, G1R 2J6, Canada
NCT Number: NCT00721890
Green tea is extracted from steam treated leaves, allowing the preservation of catechins, the active elements of the infusion. Catechins are recognized for their anti-cancer activity. Catechins act on the capacity of cancer to disseminate to other organs because of their anti-protease action. Proteases are proteins capable of digesting the cancer environment and facilitating the progression of cancer cells to blood vessels which will bring them to distant organs. We know that ovarian cancer responds well to the initial treatment of chemotherapy but tends to recur rapidly. We intend to provide green tea with higher concentrations of catechins to women with complete remission of their ovarian cancer in an attempt to delay cancer relapse. We also intend to identify, with molecular technologies, the proteases involved in ovarian cancer recurrence and response to catechins. Our objective is to test the hypothesis that green tea intake may delay ovarian cancer recurrence and to develop tools to predict which women will best benefit of the addition of green tea to their initial treatment.
Looking for future studies?
Notify MeFemale
Interventional
Phase 2
Québec, Quebec, G1R 2J6, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
liquid, 4 celsius; 500 mL ID, 3 hours after meals and 1 hour before next meal; duration: to the first of the following events: 18 months or relapse
Other names: DBGT
Time frame: 36 months
Time frame: 14th and 28th patients recruted and PRN
CHU de Quebec-Universite Laval
Other
Phase II Study: Green Tea Intake for the Maintenance of Complete Remission in Women With Advanced Ovarian Carcinoma
Acronym: DBGT-OC-CR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03180294
Adnexal Diseases, Breast Carcinoma
Anaheim, California, United States
View Trial DetailsNCT05494580
Adnexal Diseases, Endocrine Gland Neoplasms
Guangzhou, China
View Trial DetailsNCT03027479
Adnexal Diseases, Body Weight
Tours, France
View Trial DetailsNCT05001347
Adnexal Diseases, Breast Diseases
Tucson, Arizona, United States
View Trial Details